Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 25/2/2021
SIETES contiene 93212 citas

 1 a 9 de 9 
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KA. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation 2007;115:1634-42. [Ref.ID 79469]
2.Tiene citas relacionadas Cita con resumen
Kronmal RA, Barzilay JI, Smith NL, Psaty BM, Kuller LH, Burke GL, Furberg C. Mortality in pharmacologically treated older adults with diabetes: The Cardiovascular Health Study, 1989-2001. PLOS Medicine 2006;3:400. [Ref.ID 78431]
DeKosky ST, Fitzpatrick A, Ives DG, Saxton J, Williamson J, López OL, Burke G, Fried L, Kuller LH, Robbins J, Tracy R, Woolard N, Dunn L, Kronmal R, Nahin R, Furberg C, for the GEMS Investigators. The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia. Contemp Clin Trials 2006;27:238-53. [Ref.ID 77108]
4.Tiene citas relacionadas Cita con resumen
Hulley S, Furberg C, Barrett-Connor E, Cauley J, Grady D, Haskell W, Knopp R, Lowery M, Satterfield S, Schrott H, Vittinghoff E, Hunninghake D, for the HERS Research Group. Noncardiovascualr disease outcomes during 6.8 years of hormone therapy. Heart and Estrogen/Progestin Replacement Study Follow-up (HERS II). JAMA 2002;288:58-66. [Ref.ID 62688]
5. Cita con resumen
Grady D, Wenger NK, Herrington D, Khan S, Furberg C, Huunighake D, Vittinghoff E, Hulley S, for the Heart and Estrogen/progestin Replacement Study Research Group. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study. Ann Intern Med 2000;132:689-96. [Ref.ID 50718]
6.Tiene citas relacionadas Cita con resumen
Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E, for the Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998;280:605-13. [Ref.ID 39714]
8.Tiene citas relacionadas Cita con resumen
Furberg C, Psaty B. JNC VI guidelines. Authors' reply. Lancet 1998;351:289-90. [Ref.ID 36840]
Furberg C. The Beta-blocker Heart Attack Trial. Br J Clin Pharmacol 1982;14:3S-6S. [Ref.ID 7417]
Seleccionar todas
 1 a 9 de 9